FDA rules Otsuka marketing claim overstates Rexulti efficacy, threatening cornerstone of huge TV push

The FDA has ruled a claim that Otsuka made again and again overstates the efficacy of Rexulti. While Otsuka, which spends big on Rexulti TV spots, has repeatedly claimed its product is proven to reduce depression symptoms 62% more than an antidepressant alone, the FDA found no basis for the figure.